US FDA has agreed to reverse the rejection of Regenxbio's (RGNX) experimental gene therapy Navsunli, WSJ reports citing sources

Newsquawk StaffPublished On the live feed at 1 more headline followed before this page went public
Newsquawk headlinesUTC

US VP Vance to speak in Switzerland at 12:00BST/07:00EDT

Merck (MRK) said the study met its primary endpoint of clinical remission according to the Modified Mayo Score at week 12, as well as key secondary endpoints

US FDA has agreed to reverse the rejection of Regenxbio's (RGNX) experimental gene therapy Navsunli, WSJ reports citing sources

Iranian President Pezeshkian says, on negotiatons, that "Good openings have been created"

China records 124mln trips over the Dragon Boat Festival holiday; total tourism spending +4% Y/Y

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free